TEIKOKU PHARMA
Live / Registered — Registered — international registration renewed (as of 11 May 2024)
What this means for you
Registered since 15 Oct 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79123060
- Registration number
- 4416497
- Mark type
- Stylized text
- Filed
- 20 Sept 2012
- Published for opposition
- 30 Jul 2013
- Registered
- 15 Oct 2013
- Attorney of record
- Bret E. Field
Goods and services
- Class 003 — Cosmetics and cleaning preparations: [ Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for personal use; perfumery; essential oils; hair lotions ]
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to all the aforesaid services
Owner
- Teikoku Pharma USA, Inc., San Jose, CA, US
- Teikoku Pharma USA, Inc., San Jose, CA, US
- Teikoku Pharma USA, Inc., San Jose, CA, US
- Teikoku Pharma UK Limited, GB
Prior registrations
Prosecution history
- 28 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 11 May 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 07 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Sept 2023 — TEAS SECTION 71 & 15 RECEIVED
- 15 Oct 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 06 Oct 2022 — INTERNATIONAL REGISTRATION RENEWED
- 17 Oct 2020 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 05 Sept 2020 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 26 Aug 2020 — INVALIDATION PROCESSED
- 21 Jul 2020 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 21 Nov 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 21 Nov 2019 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.